Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Nephrocare Health Services Legal & Regulatory

Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.

Key figures
Value₹14.79 Cr
Source

NSE filing, NSE: NEPHROPLUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Nephrocare Health Services Ltd: key numbers

Share price
₹624.30
Market cap
₹6,264 Cr
Revenue (annual)
₹998.8 Cr
Net profit (annual)
₹76.84 Cr
P/E (TTM)
73.6×Sector 53.7×
Promoter holding
58.31%-5.54% QoQ
FII holding
11.73%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nephrocare Health Services Ltd

All →

Other legal & regulatory announcements

All →